UiPath Inc. PATH shares have soared 41% over the past month, vastly outpacing the industry’s modest 6% gain. This surge comes ...

UiPath's pivot to enterprise AI, strong growth metrics, and major tech partnerships support long-term upside despite ...

We recently published 10 Stocks Investors Are Gobbling Up. UiPath Inc. (NYSE:PATH) is one of the top performers on Monday.

UiPath upgraded to Buy as new AI partnerships boost growth prospects and attractive valuation signals upside. See more on ...

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. UiPath Inc. (NYSE:PATH) is one of the best ...

UiPath has seen a modest increase in its consensus analyst price target, ticking up from $13.30 to $13.44 as updated fair value estimates filter through recent developments. This adjustment follows a ...

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

Agentic AI can simplify business, but managing disparate AI agents can also be a job in itself. UiPath’s platform helps ...

UiPath will partner with Nvidia to strengthen customer workflows with generative AI. The company is also collaborating with OpenAI and Snowflake to improve agentic automation. Today's announcements ...

Jim Cramer won't recommend UiPath as the stock had a big move and is not for him. Archer Aviation also not recommended due to ...

The stock is cheap and could have nice upside if these collaborations can help accelerate growth.

Specialty pharmacy organization recognized as one of the 25 most innovative UiPath customers leveraging agentic automation NEW PROVIDENCE, NJ, UNITED STATES, October ...